At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
cryosurgery +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Percutaneous Thoracic Cryotherapy (PTC) for Inoperable Primary Lung Cancer and Metastatic Management
In Brief
A clinical study evaluating cryosurgery and positron emission tomography for Lung Cancer and Metastatic Cancer. Completed, enrolled 40 participants across 1 site.
Detailed Summary
RATIONALE: Cryotherapy kills tumor cells by freezing them. This may be an effective treatment for primary lung cancer or lung metastases that cannot be removed by surgery. PURPOSE: This clinical trial is studying how well cryotherapy works in treating patients with primary lung cancer or lung metastases that cannot be removed by surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer, Metastatic Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2005
First PostedMar 2006
Primary CompletionJul 2011
TodayJul 2026
First PostedMar 17, 2006
Enrollment StartNov 1, 2005
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 20.3 years ago
Interventions
cryosurgeryprocedure
positron emission tomographyprocedure